New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
10:10 EDTNCLH, CCE, TMH, GNC, ACMP, RNR, COVOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Access Midstream (ACMP) downgraded to Neutral from Buy at BofA/Merrill... Coca-Cola Enterprises (CCE) downgraded to Buy from Conviction Buy at Goldman... Covidien (COV) downgraded to Fair Value from Buy at CRT Capital... GNC Holdings (GNC) downgraded to Neutral from Outperform at RW Baird... Norwegian Cruise Line (NCLH) downgraded to Neutral at SunTrust... RenaissanceRe (RNR) downgraded at JMP Securities... Team Health (TMH) downgraded to Buy from Conviction Buy at Goldman.
News For ACMP;CCE;COV;GNC;NCLH;RNR;TMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 18, 2014
09:17 EDTNCLHNorwegian Cruise Line downgraded to Hold from Buy at DNB Markets
Subscribe for More Information
09:14 EDTNCLHCruise sector won't benefit from Cuba deal for several years, says Wells Fargo
Subscribe for More Information
09:10 EDTNCLHNorwegian Cruise Line downgraded to Hold from Buy at DNB Markets
Subscribe for More Information
07:35 EDTCCECoca-Cola Enterprises board approves new $1B share repurchase plan
Subscribe for More Information
07:35 EDTCCECoca-Cola Enterprises sees FY15 EPS up 6%-8%
For 2015, CCE expects earnings per diluted share to grow in range of 6 percent to 8 percent on a comparable and currency-neutral basis. Although too early to predict the impact, based on recent rates, currency translation would negatively impact full-year 2015 earnings per diluted share by approximately 7 percent. Net sales and operating income are expected to be slightly positive on a comparable and currency-neutral basis. The company also expects 2015 free cash flow in a range of $650 million to $700 million, including the expected negative impact of currency translation based on recent rates. Capital expenditures are expected to be in a range of $325 million to $350 million. Weighted-average cost of debt is expected to be approximately 3 percent. The comparable effective tax rate for 2015 is expected to be in a range of 27 percent to 28 percent. “In the year ahead, we see our operating environment characterized by continued marketplace challenges and soft macroeconomic conditions in many areas,” said Hubert Patricot, executive vice president and president, European Group. “As our consumers and our customers continue to face the impact of these factors, we will work diligently to enhance efficiency, create a more effective and agile organization, and ultimately reignite topline growth."
07:34 EDTCCECoca-Cola Enterprises affirms FY14 comparable, currency neutral EPS growth
Subscribe for More Information
December 17, 2014
16:27 EDTNCLHOn The Fly: Closing Wrap
Subscribe for More Information
12:57 EDTNCLHOn The Fly: Midday Wrap
Subscribe for More Information
12:17 EDTNCLHEasing of Cuba restrictions pushes number of stocks higher
Subscribe for More Information
December 16, 2014
12:00 EDTCCECoca-Cola Enterprises to hold a conference call
Management holds a conference call to provide 2015 outlook will be held on December 18 at 10 am. Webcast Link
December 14, 2014
18:45 EDTNCLHCarnival, Royal Caribbean could climb 20%, Barron's says
Subscribe for More Information
December 11, 2014
15:35 EDTNCLHThree dead after fire on Norwegian cruise ship, Cruise Critic says
Subscribe for More Information
December 10, 2014
08:18 EDTGNCDeutsche Bank to hold a conference
Subscribe for More Information
December 9, 2014
12:30 EDTACMPWells Fargo to hold a symposium
Subscribe for More Information
10:23 EDTRNROn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:56 EDTRNRRenaissanceRe initiated with an Overweight at JPMorgan
Subscribe for More Information
December 8, 2014
09:20 EDTTMHTeam Health price target raised to $70 from $65 at RW Baird
Baird raised its price target on Team Health to $70 from $65 and said the stock remains their favorite PPM name entering 2015. The firm cited potential for increased estimates based on Q4 data points and bullish M&A commentary. Baird reiterated its Outperform rating on Team Health shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use